Search - tctmd.com

Displaying 1 - 20 of 632

Sort: Relevancy | Date

News Daily News

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

Michael O'Riordan

January 15, 2026

News Daily News

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Michael O'Riordan

January 09, 2026

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Daily News

Frailty Extra Risky in Young Patients With Acute MI

Caitlin E. Cox

December 04, 2025

News Daily News

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Caitlin E. Cox

November 24, 2025

News Conference News AHA 2025

Beta-blockers Not Helpful After MI in Patients With Preserved EF

Yael L. Maxwell

November 12, 2025

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Daily News

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

Todd Neale

October 03, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

Most PCIs in US Now Done With Radial Access

Michael O'Riordan

July 10, 2025

News Daily News

Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes

Michael O'Riordan

June 20, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

Advertisement

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

Lp(a) Linked to 30-Year CVD Risk in Healthy Women

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Frailty Extra Risky in Young Patients With Acute MI

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Beta-blockers Not Helpful After MI in Patients With Preserved EF

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

Risk Factors Present in Nearly All Patients Who Develop CVD

September 2025 Dispatch for the CV Team

CVD Still the Leading Cause of Death and Disease Globally

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Most PCIs in US Now Done With Radial Access

Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content